KM, B., CH, B., E, G., JM, K., MJ, C., RR, G., . . . M, P. (2024). Study protocol: Phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer. Therapeutic advances in medical oncology, 16, 17588359231217959. https://doi.org/10.1177/17588359231217959
Chicago Style (17th ed.) CitationKM, Burcher, et al. "Study Protocol: Phase II Study to Evaluate the Effect of Cetuximab Monotherapy After Immunotherapy with PD-1 Inhibitors in Patients with Head and Neck Squamous Cell Cancer." Therapeutic Advances in Medical Oncology 16 (2024): 17588359231217959. https://doi.org/10.1177/17588359231217959.
MLA (9th ed.) CitationKM, Burcher, et al. "Study Protocol: Phase II Study to Evaluate the Effect of Cetuximab Monotherapy After Immunotherapy with PD-1 Inhibitors in Patients with Head and Neck Squamous Cell Cancer." Therapeutic Advances in Medical Oncology, vol. 16, 2024, p. 17588359231217959, https://doi.org/10.1177/17588359231217959.
